Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

41.58 -0.68 (-1.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Cologuard's Improved Performance to Accelerate Growth, Analyst Raises Expectations
Tuesday, Exact Sciences Corp (NASDAQ: EXAS) announced topline results from the pivotal BLUE-C study, showing that next-generation  
Via Benzinga
Canaccord Genuity Maintains Buy Rating for Exact Sciences: Here's What You Need To Know
Via Benzinga
Stock Market Pulls Back After Several Weeks Of Gains: Weekly Review
But the major indexes and leading stocks generally showed healthy action. 
Via Investor's Business Daily
Exact Sciences Set To Dominate Emerging Precision Oncology Market: Analyst Applauds $18B Potential Market
Benchmark analyst Bruce D. 
Via Benzinga
2 Stocks to Invest $500 In and Hold For 10 Years
Both companies have outperformed the market over the past year. 
Via The Motley Fool
Exact Sciences Stock Is Trading Higher: What's Going On?
Exact Sciences Corp (NASDAQ: EXAS) shares are trading higher Wednesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for  
Via Benzinga
What 8 Analyst Ratings Have To Say About Exact Sciences
Via Benzinga
1 Unstoppable Growth Stock to Buy and Hold for 10 Years
This company is finding success in fighting one of the deadliest illnesses. 
Via The Motley Fool
Why Exact Sciences Stock Roared Higher This Week
The cancer diagnostic company's Q1 report was full of good news for shareholders. 
Via The Motley Fool
Why Exact Sciences Stock Is Moving Higher After Hours
Exact Sciences Corp (NASDAQ: EXAS) shares are rising in extended trading Tuesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for  
Via Benzinga
Why Exact Sciences Stock With 219% Growth Could Surge Again
The company is trying to top its own success in colon cancer screening. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Revolutionary Companies With Trillion-Dollar Potential
These are just a few of the trillion-dollar potential companies to put on your radar screen for the second half. 
Via InvestorPlace
This Analyst With 87% Accuracy Rate Sees Around 16% Upside In Home Depot - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
The S&P 500 settled higher on Friday, surpassing the 4,300 level for the first time since August. The index also recorded gains for four weeks in a row. 
Via Benzinga
Expert Ratings for Exact Sciences
Via Benzinga
Why Shares of Exact Sciences Rose on Wednesday
The diagnostic testing company announced strong first-quarter earnings. 
Via The Motley Fool
Exact Sciences (EXAS) Q1 2023 Earnings Call Transcript
EXAS earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Why Top 2% Stock Exact Sciences Is On An Eight-Month Hot Streak — And Nearing A Profit-Taking Zone
The colon cancer screening market is vast, and underserved. Exact Sciences wants to change that. 
Via Investor's Business Daily
Cathie Wood Is Buying the SEC Lawsuit Dip in Coinbase (COIN) Stock
Coinbase and the crypto industry at large is at war with regulators. But Cathie Wood is still buying shares of COIN stock. 
Via InvestorPlace
Cathie Wood Onto 'Next Thing' In AI After ARK's Nvidia Exit: What's On Her Radar?
Via Benzinga
3 High-Flying Cathie Wood Stocks That Are Up Over 50% This Year
Is it too late to buy these rebounding stocks? 
Via The Motley Fool
3 AI Stocks That Famed Investor Cathie Wood Is Betting On
Exact Sciences will look to leverage AI to revolutionize its industry. Here are some other Cathie Wood AI stocks to consider too. 
Via InvestorPlace
3 Personalized Medicine Stocks to Buy for Long-Time Returns
Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out. 
Via InvestorPlace
A Bull Market Is Coming: 1 Supercharged Growth Stock to Buy Hand Over Fist Before It Soars 164%, According to Wall Street
This stock has been crushed by macroeconomic headwinds but could rebound big time if analysts are right. 
Via The Motley Fool
Cathie Wood's Flagship ARK ETF Marks 5-Day Winning Streak — Outperforming Nasdaq, FAANG In May
Cathie Wood's flagship fund Ark Innovation ETF (ARCA: ARKK) marked a five-day winning streak on Wednesday for the first time since January, as a lower-than-expected U.S. 
Via Benzinga
Exact Sciences Guidance Beat Street View, Analyst Says Company Fires All Cylinders
Exact Sciences Corp's (NASDAQ: EXAS) Q1 revenues increased 24% Y/Y to $602 million, beating the average Wall Street esti 
Via Benzinga
Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
Via Benzinga
EXAS Stock Earnings: Exact Sciences Beats EPS, Revenue Estimates
EXAS stock posted Q1 results that include a loss per share of 42 cents and revenue that was much better than analysts expected. 
Via InvestorPlace
Exact Sciences Posts Its 11th Consecutive Sales Beat As It Targets 'The Most Preventable' Cancer
The company sells Cologuard, a test to screen for colon cancer. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.